Pharmaceutical

EMA’s CHMP recommends Sanofi’s Sarclisa approval for mu...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human...

Trump picks vaccine sceptic RFK Jr to lead HHS in new a...

If confirmed as the HHS Secretary by the US Senate, RFK Jr will oversee federal ...

EMA committee rethinks stance and recommends Leqembi fo...

Following a re-evaluation, the EMA has recommended Eisai and Biogen’s Alzheimer’...

Leading account and intent-based sales and marketing pr...

Discover the top sales and marketing intelligence solutions tailored for the pha...

Pfizer considers divestiture of hospital drugs business

Pfizer is currently assessing the potential divestiture of its hospital drugs un...

FDA clears Novavax to resume trials of Covid-19 and flu...

The FDA agreed for Novavax to continue trials of its vaccine combo after address...

NHS launches “game-changer” and lifesaving anti-smoking...

Varenicline, taken once-a-day, reduces cravings for nicotine and helps with with...

Are dry powder inhalers the key to sustainable respirat...

Though prescribing climate-friendly dry powder inhalers is environmentally sound...

DMTs are major clinical research focus for Parkinson’s ...

GlobalData analysis suggests that the research and development of DMTs and non-m...

Uppsala and KTH Royal develop antibody for potential ca...

A team of researchers from Uppsala University and KTH Royal Institute of Technol...

IDWeek 2024: strategic approaches and challenges in mpo...

At IDWeek 2024 in Los Angeles, California, recent updates on mpox (formerly know...

Zai Lab and argenx announce NMPA approval for sBLA for ...

Zai Lab and argenx have announced receipt of approval from the National Medical ...

FDA grants breakthrough status to J&J’s nipocalimab for...

The US Food and Drug Administration (FDA) has awarded the second breakthrough th...

Pharmaceutical Technology Excellence Awards 2024: Bosto...

BostonGene is a winner in four categories in the 2024 Pharmaceutical Technology ...

Dizal seeks FDA approval for NSCLC treatment sunvozertinib

Dizal has submitted sunvozertinib’s new drug application (NDA) to the US Food an...

Investment surges, hurdles and emerging innovations in ...

Experts in the neuropsychiatry drug development space say targeting the right pa...